Retrospective Observational Study of Outcomes in HER2-Positive Metastatic Breast Cancer (mBC) Patients Treated with Ado-Trastuzumab Emtansine (T-DM1) and Subsequent Treatments After T-DM1 in the United States

BACKGROUND: Limited evidence exists on real-world outcomes with ado-trastuzumab emtansine (T-DM1) treatment and the effectiveness of subsequent therapies. OBJECTIVE: This study evaluated treatment patterns and outcomes of patients treated with T-DM1 and post-T-DM1 therapy in the United States. PATIE...

Descripción completa

Detalles Bibliográficos
Autores principales: Denduluri, Neelima, Espirito, Janet L., Hackshaw, Michelle D., Wentworth, Chuck, Recchia, Tamy, Kwong, Winghan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232689/
https://www.ncbi.nlm.nih.gov/pubmed/36539672
http://dx.doi.org/10.1007/s40801-022-00340-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232689/
https://www.ncbi.nlm.nih.gov/pubmed/36539672
http://dx.doi.org/10.1007/s40801-022-00340-4

Ejemplares similares